Relay Therapeutics (RLAY) is One of the Best AI Driven Biotech Stocks, Here is Why

Relay Therapeutics (RLAY) is One of the Best AI Driven Biotech Stocks, Here is Why Muhammad Ali Khalid Thu, June 11, 2026 at 12:20 PM GMT+2 2 min read RLAY Relay Therapeutics Inc. (NASDAQ: RLAY ) is one of the 10 best AI driven biotech stocks to invest in . On May 20, JonesResearch updated its coverage on Relay Therapeutics Inc.

(NASDAQ:RLAY) after reviewing encouraging initial data for its drug, zovegalisib. The firm upgraded its rating on the stock from a Hold to a Buy. The firm also increased its price target from $18 to $20, based on the positive early results for zovegalisib in treating vascular anomalies.

This results in a revised upside potential of almost 48%. Syda Productions/Shutterstock. com The firm said that the available data show that the treatment is demonstrating clear efficacy.

Consequently, the firm raised its estimated probability of commercial success for the drug in treating vascular malformations, doubling the metric from 20% to 40%. On May 19, the preliminary clinical outcome for Relay Therapeutics Inc. ’s (NASDAQ:RLAY) drug zovegalisib showed a 60% response rate at 12 weeks for PIK3CA-driven vascular anomalies.

It also worked well in patients who had already failed multiple past treatments. Because of these results, Raymond James told investors the drug could be way safer and more effective than what’s out there now, offering a massive commercial opportunity. As a result, the firm reiterated its Strong Buy rating on the stock and raised the price target from $23 to $26.

Relay Therapeutics Inc. (NASDAQ:RLAY) operates as a clinical-stage precision medicines company. The company’s lead product candidates include RLY-8161, lirafugratinib (RLY-4008), RLY-2608, and aGal chaperone.

It has strategic alliances with entities such as Elevar Therapeutics, Pfizer, and D. E. Shaw Research for the development of several therapeutic drugs.

While we acknowledge the potential of RLAY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the   best short-term AI stock . READ NEXT:  33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years .

Disclosure: None. Follow Insider Monkey on Google News .